FDA's Shorten Review Time is a Bad Sign for Puma Biotech's Controversial Cancer Drug

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"FDA's Shorten Review Time is a Bad Sign for Puma Biotech's Controversial Cancer Drug" ALT"FDA's Shorten Review Time is a Bad Sign for Puma Biotech's Controversial Cancer Drug"April…

Continue ReadingFDA's Shorten Review Time is a Bad Sign for Puma Biotech's Controversial Cancer Drug

It's Officially the End of the Road for Massachusetts Biotech Nuclea Biotechnologies

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks-down3.jpg" NAME"It's Officially the End of the Road for Massachusetts Biotech Nuclea Biotechnologiess" ALT"It's Officially the End of the Road for Massachusetts Biotech Nuclea Biotechnologies"April 19, 2017By Mark Terry...…

Continue ReadingIt's Officially the End of the Road for Massachusetts Biotech Nuclea Biotechnologies

Why Former Medivation CEO and a Once-Failed Alzheimer's Drug Could be a Recipe for Disaster for Axovant

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Why Former Medivation CEO and a Once-Failed Alzheimer's Drug Could be a Recipe for Disaster for Axovant" ALT"Why Former Medivation CEO and a Once-Failed Alzheimer's Drug Could be…

Continue ReadingWhy Former Medivation CEO and a Once-Failed Alzheimer's Drug Could be a Recipe for Disaster for Axovant

Hanmi Pharma Charged for Failure to Report Patient Death in Olmutinib Study

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-scientists3.jpg" NAME"Hanmi Pharma Charged for Failure to Report Patient Death in Olmutinib Study" ALT"Hanmi Pharma Charged for Failure to Report Patient Death in Olmutinib Study"April 18, 2017By Alex Keown,…

Continue ReadingHanmi Pharma Charged for Failure to Report Patient Death in Olmutinib Study